Cincinnati, OH, United States of America

Frank Hallock Ebetino

This inventor holds 40 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Bisphosphonate Compounds. Top assignees: The Procter Gamble Company, Biovinc LLC, Norwich Eaton Pharmaceuticals, Inc.. Active years: 1989-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frank Hallock Ebetino. Retrieved from https://idiyas.com/inventor/frank-hallock-ebetino

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 40 

% Patents Active = 80.0

 

 

Average Co-Inventor Count = 3.2

ph-index = 9

Forward Citations = 266(Granted Patents)


Location History:

  • Norwich, NY (US) (1989 - 1996)
  • Cincinnati, OH (US) (1995 - 2014)
  • Pasadena, CA (US) (2020 - 2023)
  • Venice, FL (US) (2020 - 2023)

Company Filing History:


Years Active: 1989-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Bisphosphonate Compounds
Bone Disorders
Antimicrobial Formulations
Pharmaceutical Compositions
Heterocyclic Phosphonates
Melanocortin Receptor Ligands
Phosphonocarboxylate Compounds
Chemical Conjugates
Synthetic Processes
Pharmaceutical Applications
Skeletal Diseases
Dioxin Assays
40 patents (USPTO):Explore Patents

Title: Spotlight on Inventor Frank Hallock Ebetino

Introduction:

Frank Hallock Ebetino is a prolific inventor based in Cincinnati, Ohio, with an impressive portfolio of 28 patents. His innovative work has made significant contributions to the field of pharmaceuticals, particularly in the treatment of bone-related diseases.

Latest Patents:

Among his latest patents is the groundbreaking invention of Bisphosphonate Quinolone Conjugates and uses thereof. These compounds and pharmaceutical formulations have the potential to revolutionize the treatment of bone-related diseases by coupling bisphosphonates with quinolones to enhance effectiveness.

Another recent patent by Ebetino focuses on materials and methods for suppressing and treating bone-related diseases and symptoms induced by multiple myeloma. These innovative methods offer hope for more effective treatments and improved outcomes for patients suffering from these conditions.

Career Highlights:

Throughout his career, Frank Hallock Ebetino has worked with reputable companies such as The Procter & Gamble Company and Biovinc LLC. His expertise and dedication to innovation have played a pivotal role in the success of these organizations and have led to groundbreaking developments in the pharmaceutical industry.

Collaborations:

Ebetino has collaborated with talented individuals in his field, including coworkers Adam W. Mazur and Susan Mary Kaas. Through these collaborations, he has been able to exchange ideas, drive innovation, and achieve new milestones in his inventions and patents.

Conclusion:

Inventor Frank Hallock Ebetino's relentless pursuit of innovation and his commitment to advancing medical science have established him as a prominent figure in the field of pharmaceutical research. His patents and inventions continue to impact the lives of individuals worldwide, offering hope for improved treatments and better outcomes for those affected by bone-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…